{{Drugbox
| verifiedrevid =  
| IUPAC_name =  
| image = Tazolol.svg
<!--Clinical data-->
| tradename =  
| pregnancy_category =  
| legal_status =  
| routes_of_administration =  
<!--Pharmacokinetic data-->
| bioavailability =  
| metabolism =  
| excretion =  
<!--Identifiers-->
| CAS_number = 39832-48-9
| ATC_prefix = none
| PubChem = 71721
| DrugBank =  
| ChemSpiderID = 64770
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = B64Q38TX4G
| synonyms =  
<!--Chemical data-->
| C=9 | H=16 | N=2 | O=2 | S=1
| smiles =  
}}
'''Tazolol''' is a [[beta blocker]] with some utility in the treatment of [[Cardiovascular disease|heart disease]].<ref>{{cite journal |journal = Arch Int Pharmacodyn Ther. |year = 1976 |volume = 222 |issue = 2 |pages = 200â€“15 |title = The cardiovascular pharmacology and hemodynamic activity of tazolol, a selective myocardial beta-stimulant |author = Strosberg AM. |pmid=010864}}</ref>

==See also==
*[[Timolol]]
*[[Niridazole]]
*[[Fenclozic acid]]

== References ==
{{Reflist}}

{{Antihypertensives}}

[[Category:Antiarrhythmic agents]]
[[Category:Beta blockers]]
[[Category:Thiazoles]]
[[Category:Ethers]]
[[Category:Alcohols]]
[[Category:Amines]]
[[Category:Abandoned drugs]]


{{Cardiovascular-drug-stub}}